cannabidiol
U.S. Sales of Herbal Supplements Increased in 2023
According to American Botanical Council (ABC)’s 2023 Herb Market Report, U.S. consumers spent an additional $533 million on herbal supplements in 2023 compared to 2022, a 4.4 percent increase in annual sales. The 2023 report is based on U.S. retail sales data provided by SPINS and Nutrition Business Journal (NBJ). The report was co-written by Tyler ...
NPA Files Citizen’s Petition With FDA on Specific CBD Relief
On Feb. 22, in a Citizen’s Petition to the U.S. Food and Drug Administration (FDA), the Natural Products Association (NPA) requested the FDA either: Determine cannabidiol (CBD) is not excluded from the definition of a dietary supplement under 21 U.S.C. §321(ff)(3)(B) allowing the Commissioner the ability to exercise enforcement discretion in a specific and selective ...
Innovation Strategies to Deliver CBD Products With Speed and Confidence
It’s a new year, and 2022 has the potential to be remembered as the year when minor cannabinoids achieved major status. It’s true that the cannabis market is generally interested in tetrahydrocannabinol (THC), the intoxicating cannabinoid that most marijuana consumers have come to know and love, as well as cannabidiol (CBD). But cannabinoids, such as ...
AHPA Updates Proposition 65 Hemp Industry Guidance Following Passage of California AB 45
The American Herbal Products Association (AHPA) has published an update to its Guidance on California Proposition 65 and Hemp Products to recognize the impact of the passage of California AB 45 Industrial hemp products, which was signed into law by Governor Gavin Newsome on Oct. 6, 2021. The AHPA document provided guidance to the hemp industry about ...
California Legalizes CBD in Dietary Supplements, Food and Cosmetics
On Oct. 6, California Governor Gavin Newsom signed AB 45, legalizing cannabidiol (CBD) in dietary supplements, food and cosmetics. AB 45 will allow CBD and other parts of the hemp plant to be included in food, beverages and cosmetics in California upon rigorous testing and regulatory requirements. The law also prohibits all forms of THC in ...
Associations Denounce FDA Rejection of NDI Notifications for Hemp Extract Containing CBD
The Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA) have denounced the U.S. Food and Drug Administration’s (FDA) rejection of two new dietary ingredient (NDI) notifications for full-spectrum hemp extract containing cannabidiol (CBD)—and urged Congress to act on pending legislative proposals that require the agency to address the lack of regulation of hemp-derived ...
DSM Partners With Cannabinoid Ingredient Manufacturer Mile High Labs
Royal DSM (Heerlen, The Netherlands) has announced it has entered into a broad commercial partnership with industry-leading cannabinoid ingredients and finished products manufacturer, Mile High Labs (MHL, Broomfield, CO). The partnership extends DSM’s capabilities as an innovative, end-to-end partner in nutrition and health—creating a platform from which leading consumer products companies can deliver novel, health-benefit ...
Bipartisan Legislation Introduced Would Create Regulatory Pathways for Use of Hemp-derived CBD in Dietary Supplements and Conventional Food
On May 19, Senators Ron Wyden and Jeff Merkley (D-OR) and Senator Rand Paul (R-KY) introduced bipartisan legislation that would protect public health by providing legal clarity in the hemp and hemp-derived cannabidiol (CBD) product marketplace. The Hemp Access and Consumer Safety Act of 2021 would amend the Federal Food, Drug and Cosmetic Act (FD&CA) ...
FDA Warns Selling of Topical CBD Products Violates FD&C Act
On March 22, the U.S. Food and Drug Administration (FDA) stated that it has issued warning letters to two companies for selling topical pain relief products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug and Cosmetic Act (FD&C Act). Specifically, the warning letters addressed the illegal marketing of unapproved drugs ...
CRN: New FDA Announcement on CBD Signals Continued Agency Inaction
In response to a notice issued on Jan. 8, 2021, from the U.S. Food and Drug Administration (FDA), titled, “Better Data for a Better Understanding of the Use and Safety Profile of Cannabidiol (CBD) Products,” the Council for Responsible Nutrition (CRN) issued the following statement: “Today’s notice, late in the day, late in a week that ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
